منابع مشابه
Oncology Drug Shortages in America
J Adv Pract Oncol 2012;3:96–102 T he issue of drug shortages is only one of the many crucial concerns facing oncology advanced practitioners (APs) in the United States today. However, it may be the most critical issue affecting shortand long-term patient outcomes. Shortterm outcomes may be affected by treatment delays, treatment with less effective alternatives, and increased toxicity. Long-ter...
متن کاملPediatric oncology drug shortages: a multifaceted problem.
The consensus statement by Unguru et al concerning national shortages of therapies used to treat children with cancer accomplishes 2 important tasks: it highlights a serious public health threat and proposes steps to address the problem. The working group (WG) has outlined 6 recommendations. All are constructive approaches and, in the case of the recommendations that are within US Food and Drug...
متن کاملChemotherapy drug shortages in pediatric oncology: a consensus statement.
Shortages of essential drugs, including critical chemotherapy drugs, have become commonplace. Drug shortages cost significant time and financial resources, lead to adverse patient outcomes, delay clinical trials, and pose significant ethical challenges. Pediatric oncology is particularly susceptible to drug shortages, presenting an opportunity to examine these ethical issues and provide recomme...
متن کاملDrug shortages: causes and cautions.
Drug shortages have increasingly been a problem for pharmacists and clinicians over the past decade. Clinicians need to be aware of the various causes of drug shortages and the issues that may arise as a result, particularly as they relate to medication safety. Numerous resources and strategies are available to mitigate the effects of drug shortages, and clinicians should work with their health...
متن کاملDrug shortages derail CCGs' budgets.
Financial plans of clinical commissioning groups are being derailed by emergency hikes in prices of generic drugs, which have led to soaring costs, The BMJ has learnt. Last month The BMJ reported that ongoing shortages of generic drugs cost the NHS £38m in November 2017, as the government agreed more emergency price increases to boost stocks. An examination of board papers by The BMJ has found ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the Advanced Practitioner in Oncology
سال: 2012
ISSN: 2150-0878
DOI: 10.6004/jadpro.2012.3.2.4